Research achievements in child psychiatry, adolescent psychiatry, psychosomatic medicine, and psychotherapy, 2003-2008: Attention deficit hyperactivity disorder;Forschungsleistung der deutschen kinder- und jugendpsychiatrie, psychosomatik und psychotherapie 2003-2008: Aufmerksamkeitsdefizit/- hyperaktivitätsstörung

Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie

Volumn 37, Issue 4, 2009, Pages 250-265

  Banaschewski, Tobias ^a   Konrad, Kerstin ^a   Rothenberger, Aribert ^a   Hebebrand, Johannes ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPHENIDATE; PSYCHOTROPIC AGENT; CENTRAL STIMULANT AGENT;

ADOLESCENT; ATTENTION DEFICIT DISORDER; AUTISM; BIPOLAR DISORDER; BORDERLINE STATE; CHILD; CHILD PSYCHIATRY; CLINICAL RESEARCH; CLINICAL TRIAL; COMORBIDITY; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENOME ANALYSIS; GERMANY; HUMAN; NEUROCHEMISTRY; NEUROPHYSIOLOGY; NEUROPSYCHOLOGY; NONHUMAN; PARKINSON DISEASE; PERSONALITY DISORDER; PSYCHOLOGIC ASSESSMENT; PSYCHOTHERAPY; REVIEW; RISK FACTOR; TIC; ANIMAL; BRAIN; DISEASE MODEL; GENETIC PREDISPOSITION; GENETICS; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PSYCHOLOGICAL ASPECT;

ADOLESCENT; ANIMALS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BRAIN; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; COMBINED MODALITY THERAPY; DISEASE MODELS, ANIMAL; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; METHYLPHENIDATE; PSYCHOTHERAPY;

EID: 70349243139     PISSN: 14224917     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (228)

1. Albrecht B, Banaschewski T, Brandeis D, Heinrich H, Rothenberger A: Response inhibition deficits in externalizing child psychiatric disorders: An ERP-study with the Stop-task. Behav Brain Funct 2005; 1: 22. (Pubitemid 44848773)
2. Albrecht B, Brandeis D, Uebel H, Heinrich H, Müller UC, Hasselhorn M, Steinhausen HC, Rothenberger A, Banaschewski T: Action monitoring in boys with ADHD, their nonaffected siblings and normal controls: evidence for conflict monitoring as an endophenotype for ADHD. Biol Psychiatry 2008; 64: 615-625.
3. Albrecht B, Rothenberger A, Sergeant J, Tannock R, Uebel H, Banaschewski T. Interference control in attention-deficit/hyperactivity disorder: differential stroop effects for colour-naming versus counting. J Neural Transm 2008: 2: 241-247 (Pubitemid 351270110)
4. Allen AJ, Michelson D, Kelsey D, Heiligenstein J, Faries D, Sumner C, Dittmann RW, Linde I, Thomason C: Einmal oder zweimal tägliche Dosierung von Atomoxetin in der Behandlung von Kindern und Jugendlichen mit ADHS? In: Die Sprache in der Kinder- und Jugendpsychiatrie - Zur Bedeutung kommunikativer Prozesse in Diagnostik, Therapie und Forschung. Hrsg: Resch F. Vandenhoeck & Ruprecht, Göttingen; S. 271-272, 2005.
5. Andreou P, Neale BM, Chen W, Christiansen H, Gabriels I, Heise A, Meidad S, Muller UC, Uebel H, Banaschewski T, Manor I, Oades R, Roeyers H, Rothenberger A, Sham P, Steinhausen HC, Asherson P, Kuntsi J: Reaction time performance in ADHD: improvement under fast-incentive condition and familial effects. Psychol Med 2007; 37: 1703-1715 (Pubitemid 350100437)
6. Anney RJ, Hawi Z, Sheehan K, Mulligan A, Pinto C, Brookes KJ, Xu X, Zhou K, Franke B, Buitelaar J, Vermeulen SH, Banaschewski T, Sonuga-Barke E, Ebstein R, Manor I, Miranda A, Mulas F, Oades RD, Roeyers H, Rommelse N, Rothenberger A, Sergeant J, Steinhausen HC, Taylor E, Thompson M, Asherson P, Faraone SV, Gill M. Parent of origin effects in attention/deficit hyperactivity disorder (ADHD): Analysis of data from the international multicenter ADHD genetics (IMAGE) program. Am J Med Genet B Neuropsychiatr Genet 2008; 147B: 1495-1500.
7. Asherson P, Brookes K, Franke B, Chen W, Gill M, Ebstein RP, Buitelaar J, Banaschewski T, Sonuga-Barke E, Eisenberg J, Manor I, Miranda A, Oades RD, Roeyers H, Rothenberger A, Sergeant J, Steinhausen HC, Faraone SV: Confirmation that a specific haplotype of the dopamine transporter gene is associated with combined-type ADHD. Am J Psychiat 2007; 164: 674-677 (Pubitemid 46650201)
8. Asherson P, Zhou K, Anney RJ, Franke B, Buitelaar J, Ebstein R, Gill M, Altink M, Arnold R, Boer F, Brookes K, Buschgens C, Butler L, Cambell D, Chen W, Christiansen H, Feldman L, Fleischman K, Fliers E, Howe-Forbes R, Goldfarb A, Heise A, Gabriëls I, Johansson L, Lubetzki I, Marco R, Medad S, Minderaa R, Mulas F, Müller U, Mulligan A, Neale B, Rijsdijk F, Rabin K, Rommelse N, Sethna V, Sorohan J, Uebel H, Psychogiou L, Weeks A, Barrett R, Xu X, Banaschewski T, Sonuga-Barke E, Eisenberg J, Manor I, Miranda A, Oades RD, Roeyers H, Rothenberger A, Sergeant J, Steinhausen HC, Taylor E, Thompson M, Faraone SV. A high-density SNP linkage scan with 142 combined subtype ADHD sib pairs identifies linkage regions on chromosomes 9 and 16. Mol Psychiatry 2008; 13: 514-521 (Pubitemid 351556032)
9. Augustin M, Gehrmann J: Aufmerksamkeitsdefizit-/ Hyperaktivitätsstörungen und Substanzabusus. Kinderärztliche Praxis 2008; 79: 26-30.
10. Banaschewski T, Rothenberger A: Eine Evaluation des sensomotorischen Trainings bei Kindern mit ADHS. Motorik 2006; 29: 57-64.
11. Banaschewski T, Brandeis D, Heinrich H, Albrecht B, Brunner E, Rothenberger A: Association of ADHD & conduct disorder - brain electrical evidence for the existence of a distinct subtype. J Child Psychol Psychiatry 2003; 44: 356-376 (Pubitemid 36943971)
12. Banaschewski T, Brandeis D, Heinrich H, Albrecht B, Brunner E, Rothenberger A: Questioning inhibitory control as the specific deficit of ADHD - evidence from brain electrical activity. J Neural Transm 2004; 111: 841-864 (Pubitemid 38916279)
13. Banaschewski T, Neale BM, Rothenberger A, Roessner V: Comorbidity of tic disorders & ADHD: conceptual and methodological considerations. Eur Child Adolesc Psychiatry 2007; 16 (Suppl 1): 5-14. (Pubitemid 47245228)
14. Banaschewski T, Ruppert S, Tannock R, Albrecht B, Becker A, Uebel H, Sergeant JA, Rothenberger A: Colour perception in ADHD. J Child Psychol Psychiatry 2006; 47: 568-572
15. Banaschewski T, Uebel H, Fischer R, Rothenberger A: Methylphenidat - Behandlung von Kindern und Jugendlichen mit hyperkinetischen Störungen - eine Anwendungsbeobachtung bei niedergelassenen Ärzten. Nervenheilkunde 2003; 6: 311-317
16. Banaschewski T, Woerner W, Becker A, Rothenberger A: Diagnostics for attention deficit-hyperactivity: support provided by a parental questionnaire to assess strengths and difficulties of the child (SDQ). Montaschr Kinderh 2004; 152: 778-781 (Pubitemid 39050216)
17. Banaschewski T, Yordanova J, Kolev V, Heinrich H, Albrecht B, Rothenberger A: Stimulus context and motor preparation in attention-deficit/ hyperactivity disorder. Biol Psychol 2008; 77: 53-62. (Pubitemid 350309709)
18. Barry RJ, Clarke AR, Johnstone SJ, Oades RD: Electrophysiology in attention-deficit/hyperactivity disorder. Int J Psychophysiol 2005; 58: 1-3.
19. Baving L, Rellum T, Laucht M, Schmidt MH: Children with oppositional-defiant disorder display deviant attentional processing independent of ADHD symptoms. J Neural Transm 2006; 113: 685-693 (Pubitemid 43673607)
20. Becker K, El-Faddagh M, Schmidt MH, Esser G, Laucht M: Interaction of dopamine transporter genotype with prenatal smoke exposure on ADHD symptoms. J Pediatr 2008; 152: 263-269
21. Becker K, Holtmann M, Laucht M, Schmidt MH: Are regulatory problems in infancy precursors of later hyperkinetic symptoms? Acta Paediatrica 2004, 93:1463-1469
22. Becker K, Holtmann M, Sinzig JK: EEG in routine diagnostics in ADHD: optional or essential? Developmental Medicine and Child Neurology 2004; 46: 431-432
23. Becker K, Jennen-Steinmetz C, Schmidt MH. Ist die Wender Utah Rating Scale (WURS) wirklich geeignet retrospektiv Symptome einer Hyperkinetischen Störung bzw. Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung im Kindesalter zuverlässig zu erfassen? Nervenheilkunde 2005; 26, 5: 411-416
24. Becker A, Roessner V, Rothenberger A, Banaschewski T: Anwendung des SDQ-Elternfragebogen und Diagnosestellung einer ADHS. Kinderärztl Prax 2006, 77: 230-235
25. Becker A, Steinhausen H C, Baldursson G, Dalsgaard S, Lorenzo M J, Ralston S J, Döpfner M, Rothenberger A, Adore Study Group: Psychopathological screening of children with ADHD: Strengths and Difficulties Questionnaire in a pan-European study. Eur Child Adolesc Psychiatry 2006 (Suppl 1); 15: I/56-I/62. (Pubitemid 46009497)
26. Bliznakova L, Gerstner S, Schmidt MH, Becker K. Der Methylphenidat- Doppelblindversuch - Indikation und Durchführung. Klinische Pädiatrie 2007, 9-16.
27. Breuer D, Döpfner M: Aufmerksamkeitsdefizit-/ Hyperaktivitätsstörungen bei Drei- bis Sechsjährigen in der ärztlichen Praxis - eine bundesweite Befragung. Zeitschr Kinder Jugendpsychiat Psychother 2006; 34: 357-365 (Pubitemid 44510469)
28. Brieber S, Neufang S, Bruning N, Kamp-Becker I, Remschmidt H, Herpertz-Dahlmann B, Fink GR, Konrad K: Structural brain abnormalities in adolescents with autism spectrum disorder and patients with attention deficit/hyperactivity disorder. J Child Psychol Psychiat 2007; 48:1251-1258 (Pubitemid 350256552)
29. Brookes K, Xu X, Chen W, Zhou K, Neale B, Lowe N, Anney R, Aneey R, Franke B, Gill M, Ebstein R, Buitelaar J, Sham P, Campbell D, Knight J, Andreou P, Altink M, Arnold R, Boer F, Buschgens C, Butler L, Christiansen H, Feldman L, Fleischman K, Fliers E, Howe-Forbes R, Goldfarb A, Heise A, Gabriëls I, Korn-Lubetzki I, Johansson L, Marco R, Medad S, Minderaa R, Mulas F, Müller U, Mulligan A, Rabin K, Rommelse N, Sethna V, Sorohan J, Uebel H, Psychogiou L, Weeks A, Barrett R, Craig I, Banaschewski T, Sonuga-Barke E, Eisenberg J, Kuntsi J, Manor I, McGuffin P, Miranda A, Oades RD, Plomin R, Roeyers H, Rothenberger A, Sergeant J, Steinhausen HC, Taylor E, Thompson M, Faraone SV, Asherson P: The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes. Mol Psychiatr 2006; 11: 934-953 (Pubitemid 44470216)
30. Brookes KJ, Neale B, Xu X, Thapar A, Gill M, Langley K, Hawi Z, Mill J, Taylor E, Franke B, Chen W, Ebstein R, Buitelaar J, Banaschewski T, Sonuga-Barke E, Eisenberg J, Manor I, Miranda A, Oades RD, Roeyers H, Rothenberger A, Sergeant J, Steinhausen HC, Faraone SV, Asherson P: Differential dopamine receptor D4 allele association with ADHD dependent of proband season of birth. Am J Med Genet B Neuropsychiatr Genet 2008; 147B: 94-99
31. Buitelaar JK, Michelson D, Danckaerts M, Gillberg C, Spencer T, Zuddas A, Faries D, Zhang S, Wehmeier P, Dittmann RW, Biederman J: Kontinuierliche Atomoxetin-Wirksamkeit nach einem Jahr Behandlung bei Kindern und Jugendlichen mit ADHS. In: Die Sprache in der Kinder- und Jugendpsychiatrie - Zur Bedeutung kommunikativer Prozesse in Diagnostik, Therapie und Forschung. Hrsg: Resch F. Vandenhoeck & Ruprecht, Göttingen; S. 43, 2005.
32. Chen W, Zhou K, Sham P, Franke B, Kuntsi J, Campbell D, Fleischman K, Knight J, Andreou P, Arnold R, Altink M, Boer F, Boholst MJ, Buschgens C, Butler L, Christiansen H, Fliers E, Howe-Forbes R, Gabriëls I, Heise A, Korn-Lubetzki I, Marco R, Medad S, Minderaa R, Müller UC, Mulligan A, Psychogiou L, Rommelse N, Sethna V, Uebel H, McGuffin P, Plomin R, Banaschewski T, Buitelaar J, Ebstein R, Eisenberg J, Gill M, Manor I, Miranda A, Mulas F, Oades RD, Roeyers H, Rothenberger A, Sergeant J, Sonuga-Barke E, Steinhausen HC, Taylor E, Thompson M, Faraone SV, Asherson P: DSMIV combined type ADHDshows familial association with sibling trait scores: A sampling strategy for QTL linkage. Am J Med Genet B Neuropsychiatr Genet. 2008; 147B: 1450-1460
33. Christiansen H, Chen W, Oades RD, Asherson P, Taylor EA, Lasky-Su J, Zhou K, Banaschewski T, Buschgens C, Franke B, Gabriels I, Manor I, Marco R, Müller UC, Mulligan A, Psychogiou L, Rommelse NN, Uebel H, Buitelaar J, Ebstein RP, Eisenberg J, Gill M, Miranda A, Mulas F, Roeyers H, Rothenberger A, Sergeant JA, Sonuga-Barke EJ, Steinhausen HC, Thompson M, Faraone SV: Co-transmission of conduct problems with attention-deficit/hyperactivity disorder: familial evidence for a distinct disorder. J Neural Transm 2008; 115: 163-175
34. Coghill D, Spiel G, Baldursson G, Döpfner M, Lorenzo MJ, Ralston SJ, Rothenberger A, ADORE Study Group*: Which factors impact on clinician-rated impairment in children with ADHD? Eur Child Adoles Psy 2006; 15 Suppl 1: i30-i37..
35. Dittmann RW, Bartel C, Deutsche ADORE/FACE Studiengruppe: Zielsetzung und Methodik von Beobachtungsstudien am Beispiel der ADORE & FACE Untersuchung (Symposium: Rothenberger A, Döpfner M: Ergebnisse einer vergleichenden Beobachtungsstudie zu ADHS: Die AORE & FACE Studie.). In: Die Sprache in der Kinder- und Jugendpsychiatrie - Zur Bedeutung kommunikativer Prozesse in Diagnostik, Therapie und Forschung. Hrsg: Resch F. Vandenhoeck & Ruprecht, Göttingen; S. 50, 2005.
36. Dlugos A, Freitag C, Hohoff C, McDonald J, Cook EH, Deckert J, de Wit H: Norepinephrine transporter gene variation modulates acute response to d-Amphetamine. Biol Psychiatry 2007; 61: 1296-1305 (Pubitemid 46726264)
37. Domschke K, Sheehan K, Lowe N, Kirley A, Mullins C, O'Sullivan R, Freitag C, Becker T, Conroy J, Fitzgerald M, Gill M, Hawi Z: Association analysis of the monoamine oxidase A and B genes with attention deficit hyperactivity disorder (ADHD) in an Irish sample: Preferential transmission of the MAO-A 941G allele to affected children. Am J Med Genet B Neuropsychiatr Genet 2005; 134: 110-114 (Pubitemid 40416788)
38. Döpfner M, Banaschewski T, Schmidt J, Uebel H, Schmeck K, Gerber WD, Günter M, Knölker U, Gehrke M, Häßler F, Möhler E, Brünger M, Ose C, Fischer R, Poustka F, Lehmkuhl G, Rothenberger A: Langwirksames Methylphenidat bei Kindern mit Aufmerksamkeitsdefizit- Hyperaktivitätsstörungen. Eine multizentrische Studie. Nervenheilkunde 2003; 22: 85-92. (Pubitemid 36401884)
39. Döpfner M, Gerber WD, Banaschewski T, Breuer D, Freisleder FJ, Gerber-von Muller G, Günter M, Hässler F, Ose C, Rothenberger A, Schmeck K, Sinzig J, Stadler C, Uebel H, Lehmkuhl G: Comparative Efficacy of once-a-day Extended-Release Methylphenidate, two-times-daily Immediate-Release Methylphenidate and Placebo in a Laboratory School Setting. Eur Child Adol Psy 2004; 13: 93-101. (Pubitemid 39165255)
40. Döpfner M, Gerber WD, Banaschewski T, Breuer D, Freisleder FJ, Gerber-von-Müller G, Günter M, Hässler F, Ose C, Rothenberger A, Schmeck K, Sinzig J, Stadler C, Uebel H, Lehmkuhl: Comparative efficacy of once-a-day extended-release methylphenidate, two-times-daily immediate-release methylphenidate, and placebo in a laboratory school setting. Eur Child Adoles Psy 2004; 13 (Suppl 1): I93-101. (Pubitemid 39165255)
41. Döpfner M, Sevecke K, Deutsche ADORE/FACE Studiengruppe (inkl. Dittmann RW): ADHS-Symptomatik im Elternurteil und in der klinischen Einschätzung. (Symposium: Rothenberger, A, Döpfner, M Ergebnisse einer vergleichenden Beobachtungsstudie zu ADHS: Die ADORE & FACE Studie.). In: Die Sprache in der Kinder- und Jugendpsychiatrie - Zur Bedeutung kommunikativer Prozesse in Diagnostik, Therapie und Forschung. Hrsg: Resch F. Vandenhoeck & Ruprecht, Göttingen; S. 52-53, 2005.
42. Döpfner M, Steinhausen HC, Coghill D, Dalsgaard S, Poole L, Ralston SJ, Rothenberger A, ADORE Study Group*: Cross-cultural reliability and validity of ADHD assessed by the ADHD Rating Scale in a pan-European study. Eur Child Adoles Psy 2006; 15 (Suppl 1): i46-i55..
43. Döpfner M, Rothenberger A: Behaviour therapy in tic-disorders with co-existing ADHD. Eur Child Adoles Psy 2007; 16 (suppl 1): I/89-I/99. (Pubitemid 47245235)
44. Döpfner M, Breuer D, Schürmann S, Wolff Metternich T, Rademacher C & Lehmkuhl G: Die Wirksamkeit von multimodaler Therapie bei Kinder mit Aufmerksamkeitsdefizit-/Hyperaktivitätsstörungen - Ergebnisse der Kölner Multimodalen Therapiestudie. In U. Lehmkuhl (Hrsg.) Psychotherapie und Psychopharmakotherapie im Kindes- und Jugendalter. Indikation, Effekte, Verlauf. (S. 135-148). Göttingen: Vandenhoeck & Ruprecht, 2003.
45. Döpfner, M, Breuer, D, Schürmann, S, Wolff Metternich, T, Rademacher, Ch, Lehmkuhl, G: Effectiveness of an adaptive multimodal treatment in children with Attention-Deficit-Hyperactivity Disorder - global outcome. European Child and Adolescent Psychiatry 2004; (Suppl. 1) 13:117-129. (Pubitemid 39165257)
46. Döpfner, M, Rothenberger, A & Sonuga-Barke, E: Areas for future investment in the field of ADHD: Preschoolers and clinical networks. European Child & Adolescent Psychiatry 2004; (Supplement 1) 13:I /130-I /135.
47. Döpfner, M, Steinhausen, H-C, David Coghill, Soren Dalsgaard, Poole, L, Ralston, SJ, Rothenberger, A & Adore Study Group. (2006f). Cross cultural reliability and validity of ADHD assessed by the ADHD Rating Scale in a pan-European study. European Child and Adolescent Psychiatry 2006f; 15, supplement 1:I/46-I/55.
48. Drechsler R, Straub M, Doehnert M, Heinrich H, Steinhausen HC, Brandeis D: Controlled evaluation of a neurofeedback training of slow cortical potentials in children with Attention Deficit/Hyperactivity Disorder (ADHD). Behav Brain Funct 2007; 3(1):35. (Pubitemid 47470223)
49. El-Faddagh M, Laucht M, Maras A, Vöhringer L, Schmidt MH. Association of DRD4 with ADHD in a community sample of children at risk for psychopathology: a longitudinal study from birth to 11 years of age. J Neural Transm 2004; 111:883-889.
50. Esser G. Fischer S, Wyschkon A, Laucht M, Schmidt MH. Vorboten hyperkinetischer Störungen: Früherkennung bereits im Säuglingsalter möglich? Z Kinder Jugendpsychiat Psychother 2007; 35:179-188.
51. Esser G, Fischer S, Wyschkon A, Laucht M, Schmidt MH: Vorboten hyperkinetischer Störungen: Früherkennung im Kleinkindalter. Z Kinder Jugendpsychiat Psychother 2007; 35:127-136. (Pubitemid 46524358)
52. Fallgatter AJ, Seifert J, Strik WK, Scheuerpflug P, Zillessen KE, Herrmann MJ, Warnke A: Altered response control and anterior cingulate function in attention-deficit/hyperactivity disorder boys. Clin Neurophysiol 2004; 115: 973-981. (Pubitemid 38293497)
53. Freitag CM, Meyer J, Reif A, Rösler M, Lesch KP, Retz W: Environmental risk factors and ADHD symptoms (letter). Arch Gen Psychiatry 2008; 65: 356-357.
54. Friedel S, Fontenla Horro F, Wermter AK, Geller F, Dempfle A, Reichwald K, Smidt J, Brönner G, Konrad K, Herpertz-Dahlmann B, Warnke A, Hemminger U, Linder M, Kiefl H, Goldschmidt HP, Siegfried W, Remschmidt H, Hinney A, Hebebrand J: Mutation screen of the brain derived neurotrophic factor gene (BDNF): Identification of several genetic variants and association studies in patients with obesity, eating disorders, and Attention-Deficit/Hyperactivity disorder. American Journal of Medical Genetics Part B (Neuropsychiatric Genetics) 2005; 132B:96-99. (Pubitemid 40066204)
55. Friedel S, Saar K, Sauer S, Dempfle A, Walitza S, Renner T, Romanos M, Freitag C, Seitz C, Palmason H, Scherag A, Windemuth-Kieselbach C, Schimmelmann BG, Wewetzer C, Meyer J, Warnke A, Lesch KP, Reinhardt R, Herpertz-Dahlmann B, Linder M, Hinney A, Remschmidt H, Schäfer H, Konrad K, Hübner N, Hebebrand J: Association and linkage of allelic variants of the dopamine transporter gene in ADHD. Mol Psychiatry 2007; 2(10): 923-933 (Pubitemid 47482693)
56. Frölich, J, Lehmkuhl, G, Wiater, A: Schlafstörungen bei hyperkinetischen Kindern - polysomnografische Untersuchungen zur Schlafstruktur und -architektur. Z Kinder- Jugendpsychiatr 2005; 33: 205-216. (Pubitemid 41103564)
57. Gille G, Klapp C, Layer C, Hazell P, Danckaerts M, Zeiner P, Barton J, Johnson M, Zhang S, Becker K, Dittmann RW, Michelson D: Beeinflusst das Vorliegen einer komorbiden oppositionellen Störung bei ADHD-Patienten das Rückfallrisiko unter Atomoxetin-Therapie? In: Kursbuch für integrative Kinder- und Jugendpsychotherapie. Schwerpunkt: Psyche und Soma. Hrsg: F. Resch&M. Schulte-Markwort, Beltz Psychologie Verlags Union, Weinheim Basel; S. 144-147, 2006.
58. Greimel E, Herpertz-Dahlmann B, Günther T, Vitt C, Konrad K: Attentional functions in children and adolescents with attention-deficit/ hyperactivity disorder with and without comorbid tic disorder J Neural Transmission. 2008;115:191-200.
59. Günther T, Herpertz-Dahlmann B, Jolles J, Konrad K: The influence of risperidone on attentional functions in children and adolescents with attention-deficit/hyperactivity disorder and co-morbid disruptive behavior disorder. J Child Adolesc Psychopharmacol. 2006; 16(6): 725-735 (Pubitemid 46175428)
60. Hanisch C, Konrad K, Günther T, Herpertz-Dahlmann B. Age-dependent neuropsychological deficits and effects of methylphenidate in children with attention-deficit/hyperactivity disorder: a comparison of pre- and grade-school children. J Neural Transm 2004; 111: 865-881. (Pubitemid 38916280)
61. Hanisch C, Radach R, Holtkamp K, Herpertz-Dahlmann B, Konrad K: Oculomotor inhibition in children with and without attention-deficit hyperactivity disorder (ADHD). J Neural Transm. 2006; 113(5): 671-684 (Pubitemid 43673606)
62. Hebebrand J, Dempfle A, Saar K, Thiele H, Herpertz-Dahlmann B, Linder M, Kiefl H, Remschmidt H, Hemminger U, Warnke A, Knölker U, Heiser P, Friedel S, Hinney A, Schäfer H, Nürnberg P, Konrad K: A genome-wide scan for attentiondeficit/ hyperactivity disorder in 155 German sib-pairs. Mol Psychiatry 2006; 11(2): 196-205. (Pubitemid 43164621)
63. Heger S, Trott GE, Meusers M, Schulz E, Rothenberger A, Rettig K, Medori R, Schreiner A, Remschmidt H, als Vertreter der CS: Umstellung von einem unretardierten auf ein retardiertes Methylphenidatpräparat: Eine multizentrische, offene Studie an Kindern mit ADHS. Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie 2006; 34:257-265.
64. Heinrich H, Gevensleben H, Freisleder FJ, Moll GH, Rothenberger A: Training of slow cortical potentials in ADHD: evidence for positive behavioral and neurophysiological effects. Biol Psychiatry 2004; 55(7):772-775.
65. Heiser P, Dempfle A, Friedel S, Konrad K, Hinney A, Kiefl H, Walitza S, Bettecken T, Saar K, Linder M, Warnke A, Herpertz-Dahlmann B, Schäfer H, Remschmidt H, Hebebrand J: Family-based association study of serotonergic candidate genes and attention-deficit/hyperactivity disorder in a German sample. J Neural Transm. 2007; 114: 513-521 (Pubitemid 46474866)
66. Heiser P, Dempfle A, Friedel S, Konrad K, Hinney A, Kiefl H, Walitza S, Bettecken T, Saar K, Linder M, Warnke A, Herpertz-Dahlmann B, Schäfer H, Remschmidt H, Hebebrand J: Family-based association study of serotonergic candidate genes and attention-deficit/hyperactivity disorder in a German sample. J Neural Transm 2007; 114: 523-526. (Pubitemid 46474866)
67. Heiser P, Frey J, Smidt J, Sommerlad C, Wehmeier PM, Hebebrand J, Remschmidt H: Objective measurement of hyperactivity, impulsivity, and inattention in children with hyperkinetic disorders before and after treatment with methylphenidate. Eur Child Adolesc Psychiatry 2004; 13:100-104 (Pubitemid 38657631)
68. Heiser P, Heinzel-Gutenbrunner M, Frey J, Smidt J, Grabarkiewicz J, Friedel S, Kühnau W, Schmidtke J, Remschmidt H, Hebebrand J: Twin study on heritability of activity, attention, and impulsivity as assessed by objective measures.J Atten Disord 2006; 9:575-581
69. Hoare P, Remschmidt H, Medori R, Ettrich C, Rothenberger A, Santosh P, Schmit M, Spender Q, Tamhne R, Thompson M, Tinline C, Trott GE: 12-month efficacy and safety of OROS MPH in children and adolescents with attention-deficit/hyperactivity disorder switched from MPH. Eur Child Adoles Psy 2005; 14(6): 305-309 (Pubitemid 41437283)
70. Holtkamp K, Konrad K, Mueller B, Heussen N, Herpertz S, Herpertz-Dahlmann B, Hebebrand J: Overweight and obesity in children with Attention-Deficit- Hyperactivity Disorder. International Journal of Obesity and Related Metabolic Disorders 2004; 28:685-689. (Pubitemid 38580977)
71. Holtmann M, Becker K, Kentner-Figura B, Schmidt MH. Increased frequency of Rolandic spikes in ADHD children. Epilepsia 2003; 44:1241-1244 (Pubitemid 37100052)
72. Holtmann M, Bölte, S Goth, K & Poustka F: CBCL-pediatric bipolar disorder phenotype: severe ADHD or bipolar disorder? Journal of Neural Transmission 2008; 115: 155-161.
73. Holtmann M, Matei A, Hellmann U, Becker K, Poustka F, Schmidt MH. Rolandic spikes increase impulsivity in ADHD - a neuropsychological pilot study. Brain & Developm 2006; 633-640. (Pubitemid 44485949)
74. Holtmann M, Stadler C: Electroencephalographic-biofeedback for the treatment of attention-deficit/hyperactivity disorder in childhood and adolescence Expert. Review of Neurotherapeutics 2006;6:533-540. (Pubitemid 43764751)
75. Huss M, Poustka F, Lehmkuhl G, Lehmkuhl U: No increase in long-term risk of nicotine use disorder after treatment with methylphenidate in children with attention-deficit/hyperactivity disorder (ADHD): evidence from a non-randomised retrospective study. J Neural Transm 2008; 115:335-339.
76. Huss M, Stadler C, Salbach H, Mayer P, Ahle M & Lehmkuhl U: ADHS im Lehrerurteil: Ein Vergleich von Klinik- und Normstichprobe anhand der Conners-Skalen Kindheit und Entwicklung 2004; 11:90-97.
77. Jacob CP, Romanos J, Dempfle A, Heine M, Kruse A, Reif A, Walitza S, Romanos M, Strobel A, Brocke B, Schmidtke A, Böning J, Lesch KP: Co-morbidity in adult attention-deficit/hyperactivity disorder with focus on personality traits and related disorders in a clinically referred sample. Eur Arch Psychiatry Clin Neurosci 2007; 257: 309-317. (Pubitemid 47476717)
78. Jemel B, Oades RD, Oknina L, Achenbach C, Röpcke B. Frontal and temporal lobe sources for a marker of controlled auditory attention: the negative difference (Nd) event-related potential. Brain Topogr 2003; 15:249-262 (Pubitemid 36807731)
79. Kerdar MS, Scheuerpflug P, Srdinko P, Wewetzer C, Warnke A, Romanos M: Quantitative effect of treatment with methylphenidate on EEG-a pilot study. Zeitschr Kinder Jugendpsychiatr 2007; 35: 247-255. (Pubitemid 47356143)
80. Kirov R, Banaschewski T, Uebel H, Kinkelbur J, Rothenberger A: REM-sleep alterations in children with co-existence of tic disorders and attention-deficit/hyperactivity disorder: impact of hypermotor symptoms. Eur Child Adoles Psy 2007; 16 Suppl 1: 45-50. (Pubitemid 47245232)
81. Kirov R, Kinkelbur J, Banaschewski T, Rothenberger A. Sleep patterns in children with attention-deficit/hyperactivity disorder, tic disorder, and comorbidity. J Child Psychol Psychiatry 2007; 48:561-570. (Pubitemid 46902326)
82. Kirov R, Kinkelbur J, Heipke S, Kostanecka-Endress T, Westhoff M, Cohrs S, Ruther E, Hajak G, Banaschewski T, Rothenberger A: Is there a specific polysomnographic sleep pattern in children with attention deficit/hyperactivity disorder? J Sleep Res 2004; 13(1): 87-93.
83. Kirov R, Pillar G, Rothenberger A:) REM-sleep changes in children with attention-deficit/hyperactivity disorder: methodologic and neurobiologic considerations. Sleep 2004; 27(6): 1215.. (Pubitemid 39331095)
84. Kirschner J, Moll GH, Fietzek UM, Heinrich H, Mall V, Berweck S, Heinen F, Rothenberger A: Methylphenidate enhances both intracortical inhibition and facilitation in healthy adults. Pharmacopsychiatry 2003; 36(2): 79-82. (Pubitemid 36609514)
85. Kissling C, Retz W, Wiemann S, Coogan AN, Clement RM, Hünnerkopf R, Conner AC, Freitag CM, Rösler M, Thome J: A polymorphism at the 3′-untranslated region of the CLOCK gene is associated with adult attention-deficit hyperactivity disorder Am J Med Genet B Neuropsychiatr Genet 2008; 147B: 333-338.
86. Koesters M, Becker T, Kilian R, Fegert JM, Weinmann S: Limits of Meta-Analysis: Methylphenidate in the Treatment of Adult ADHD. J Psychopharmacol (in Press).
87. Konrad K, Gauggel S, Schurek J: Catecholamine functioning in children with traumatic brain injuries and children with attention-deficit/hyperactivity disorder. Cogn Brain Res 2003; 16: 425-433. (Pubitemid 36423338)
88. Konrad K, Günther T, Hanisch C, Herpertz-Dahlmann B. Differential effects of methylphenidate on attentional functions in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2004; 43: 191-198.
89. Konrad K, Günther T, Heinzel-Gutenbrunner M, Herpertz-Dahlmann B: Clinical evaluation of subjective and objective changes in motor activity and attention in children with attention-deficit/hyperactivity disorder in a double-blind methylphenidate trial. J Child Adolesc Psychopharmacol 2005;15(2):.
90. Konrad K, Neufang S, Fink GR, Herpertz-Dahlmann B: Long-term effects of methylphenidate on neural networks associated with executive attention in children with ADHD: results from a longitudinal functional MRI study. J Am Acad Child Adolesc Psychiatry 2007; 46(12): 1633-1641 (Pubitemid 350146528)
91. Konrad K, Neufang S, Hanisch C, Fink GR, Herpertz-Dahlmann B: Dysfunctional attentional networks in children with attention deficit/hyperactivity disorder: Evidence from an event-related functional magnetic resonance imaging study. Biol Psychiatry 2006; 59: 643-651. (Pubitemid 43357959)
92. Konrad K, Neufang S, Thiel CM, Specht K, Hanisch C, Fan J, Herpertz-Dahlmann B Fink GR: Development of attentional networks: an fMRI study with children and adults. Neuroimage 2005; 28: 429-439 (Pubitemid 41443512)
93. Köster, I, Schubert, I, Döpfner, M, Adam, C, Ihle, P & Lehmkuhl, G: Hyperkinetische Störungen bei Kindern und Jugendlichen: Zur Häufigkeit des Behandlungsanlasses in der ambulanten Versorgung nach den Daten der Versichertenstichprobe AOK Hessen/KV Hessen (1998-2001). Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie 2004;32:157-166.
94. Krauel K, Duzel E, Hinrichs H, Santel S, Rellum T, Baving L: Impact of emotional salience on episodic memory in attention-deficit/hyperactivity disorder: a functional magnetic resonance imaging study. Biol Psychiatry 2007; 61:1370-1379. (Pubitemid 46855769)
95. Kutcher S, Aman M, Brooks S, Buitelaar J, van Daalen E, Fegert JM, Findling RL, Fisman S, Greenhill L, Huss M, Kusumakar V, Pine D, Taylor E, Tyano S: International consensus statement on attention-deficit/hyperactivity disorder (ADHD) and disruptive behaviour disorders (DBDs): Clinical implications and treatment practice suggestions. Eur Neuropsychopharm 2004; 14: 11-28. (Pubitemid 37495027)
96. Lampe K, Konrad K, Kroener S, Fast K, Kunert HJ, Herpertz SC: Neuropsychological and behavioural disinhibition in adult ADHD compared to borderline personality disorder. Psychol Med. 2007; 37(12): 1717. (Pubitemid 350100432)
97. Lange KW, Tucha L, Walitza S, Gerlach M, Linder M, Tucha O: Interaction of attention and graphomotor functions in children with attention deficit hyperactivity disorder. J Neural Transm [Suppl] 2008; 72: 249-255
98. Lasky-Su J, Banaschewski T, Buitelaar J, Franke B, Brookes K, Sonuga-Barke E, Ebstein R, Eisenberg J, Gill M, Manor I, Miranda A, Mulas F, Oades RD, Roeyers H, Rothenberger A, Sergeant J, Steinhausen HC, Taylor E, Zhou K, Thompson M, Asherson P, Faraone SV. Partial replication of a DRD4 association in ADHD individuals using a statistically derived quantitative trait for ADHD in a family-based association test. Biol Psychiatry. 2007; 62:985-990 (Pubitemid 47570030)
99. Laucht M, Hohm E, Esser G, Schmidt MH. Erhöhtes Raucherrisiko von Kindern mit Aufmerksamkeits- und Verhaltensstörungen. Z Klin Psychol Psychiatr Psychother 2005; 34, 258-265
100. Laucht M, Hohm E, Esser G, Schmidt MH, Becker K. Association between ADHD and smoking in adolescence: Shared genetic, environmental and psychopathological factors. J Neural Transm 2007; 114:1097-1104.
101. Laucht M, Schmidt MH. Mütterliches Rauchen in der Schwangerschaft: Risikofaktor für eine ADHS des Kindes? Z Kinder Jugendpsychiat Psychother 2004; 32:177-185.
102. Laucht M, Skowronek MH, Becker K, Schulze TG, Schmidt MH, Esser G, Rietschel M. Interacting effects of the dopamine transporter gene and psychosocial adversity on ADHD symptoms among 15-year-olds from a high-risk community sample. Arch Gen Psychiatry 2007; 64:585-590. (Pubitemid 46718291)
103. Lenz D, Krauel K, Schadow J, Baving L, Duzel E, Herrmann CS: Enhanced gamma-band activity in ADHD patients lacks correlation with memory performance found in healthy children. Brain Res 2008; 1235: 117-132.
104. Ludolph AG, Kassubek J, Schmeck K, Glaser C, Wunderlich A, Buck AK, Reske SN, Fegert JM, Mottaghy FM: Dopaminergic dysfunction in attention deficit hyperactivity disorder (ADHD), differences between pharmacologically treated and never treated young adults: A 3,4-dihydroxy-6-(18F)fluorophenyl-L-alanin PET study. Neuroimage 2008; 41:718-727.
105. Ludolph AG, Pinkhardt EH, van Elst LT, Ludolph AC, Libal G, Fegert JM, Kassubek J: Amygdalar volume alterations in children with Tourette syndrome: due to ADHD comorbidity? Dev Med Child Neurol 2008; 50:524-529.
106. Lulé D, Ludolph AC, Ludolph AG: Neurodevelopmental and neurodegenerative diseases - Is there a pathophysiological link? Attention-deficit/hyperactivity disorder and amyotrophic lateral sclerosis as examples. Med Hypotheses 2008; 70:1133-1138
107. Melfsen S, Alpers GW, Walitza S, Warnke A: Angstsensitivität bei Kindern mit Aufmerksamkeits- und Hyperaktivitätsstörung. Verhaltenstherapie 2006; 16: 25-33.
108. Moll GH, Heinrich H, Rothenberger A: Methylphenidate and intracortical excitability: opposite effects in healthy subjects and attention-deficit hyperactivity disorder. Acta Psychiatr Scand 2003; 107:69-72. (Pubitemid 36092247)
109. Neale BM, Sham PC, Purcell S, Banaschewski T, Buitelaar J, Franke B, Sonuga-Barke E, Ebstein R, Eisenberg J, Mulligan A, Gill M, Manor I, Miranda A, Mulas F, Oades RD, Roeyers H, Rothenberger A, Sergeant J, Steinhausen HC, Taylor E, Thompson M, Chen W, Zhou K, Asherson P, Faraone SV. Population differences in the International Multi-Centre ADHD Gene Project. Genet Epidemiol 2008; 32:98-107. (Pubitemid 351288027)
110. Novik TS, Hervas A, Ralston SJ, Dalsgaard S, Pereira RR, Lorenzo MJ, ADORE Study Group: Influence of gender on Attention-Deficit/Hyperactivity Disorder in Europe - ADORE. Eur Child Adoles Psy 2006; 15: 15-24 Suppl. 1. (Pubitemid 46009491)
111. Oades RD, Christiansen H. Cognitive switching processes in young people with attention-deficit/hyperactivity disorder. Arch Clin Neuropsychol 2008; 23:21-32. (Pubitemid 350309499)
112. Preuss U, Ralston SJ, Baldursson G, Falissard B, Lorenzo MJ, Pereira RR, Vlasveld L, Coghill D, ADORE Study Group: Study design, baseline patient characteristics and intervention in a cross-cultural framework: results from the ADORE study. Eur Child Adoles Psy 2006; 15: 4-14 Suppl. 1. (Pubitemid 46009495)
113. Ralston SJ, Lorenzo MJ, ADORE study group: ADORE - Attention-Deficit Hyperactivity Disorder Observational Research in Europe. Eur Child Adoles Psy 2004; 13 Suppl 1: I36-42.
114. Remschmidt H, Hoare P, Ettrich C, Rothenberger A, Santosh P, Schmidt M, Spender Q, Tamhne R, Thompson M, Tinline C, Trott GE, Medori R: Symptom control in children and adolescents with attention-deficit/hyperactivity disorder on switching from immediate-release MPHto OROS MPH. Results of a 3-week open-label study. Eur Child Adoles Psy 2005; 14(6): 297-304.
115. Renner TJ, Walitza S, Dempfle A, Eckert L, Romanos M, Gerlach M, Schäfer H, Warnke A, Lesch KP, Jacob C: Allelic variants of SNAP25 in a family-based sample of ADHD. J Neural Transm 2008; 115:317-321
116. Retz W, Freitag CM, Retz-Junginger P, Wenzler D, Schneider M, Kissling C, Thome J, Rösler M: A functional serotonin transporter promoter gene polymorphism increases ADHD symptoms in delinquents: interaction with adverse childhood environment. Psychiatr Res. 2008; 158: 123-131
117. Retz W, Rösler M, Kissling C, Wiemann S, Hünnerkopf R, Coogan A, Thome A, Freitag C: Norepinephrine transporter and catecholamin-O- methyltransferase gene variants and attention-deficit/hyperactivity disorder symptoms in adults. J Neural Transm 1 2007; 15: 323-329
118. Richter MM, Ehlis AC, Böhne CG, Scheuerpflug P, Jacob CP, Fallgatter AJ: Inhibitorische Hirnfunktionen bei ADHS im Erwachsenenalter. Nervenheilkunde 2006; 8: 657-661. (Pubitemid 46173384)
119. Riley AW, Coghill D, Forrest CB, Lorenzo MJ, Ralston SJ, Spiel G, ADORE Study Group: Validity of the health-related quality of life assessment in the ADORE study: Parent Report Form of the CHIP-Child Edition. Eur Child Adoles Psy 2006; 15: 63-71 Suppl. 1. (Pubitemid 46009498)
120. Riley AW, Lyman LM, Spiel G, Dopfner M, Lorenzo MJ, Ralston SJ, ADORE Study Group: The Family Strain Index (FSI). Reliability, validity, and factor structure of a brief questionnaire for families of children with ADHD. Eur Child Adoles Psy 2006; 15: 72-78 Suppl. 1.
121. Riley AW, Spiel G, Coghill D, Doepfner M, Falissard B, Lorenzo MJ, Preuss U, Ralston SJ, ADORE Study Group: Factors related to Health-Related Quality of Life (HRQoL) among children with ADHD in Europe at entry into treatment Eur Child Adoles Psy 2006; 15: 38-45 Suppl. 1.
122. Riley AW, Lyman LM, Spiel G, Döpfner M, Lorenzo MJ, Ralston, SJ & ADORE Study Group: The Family Strain Index (FSI). Reliability, validity, and factor structure of a brief questionnaire for families of children with ADHD. European Child and Adolescent Psychiatry 2006a; 15, supplement 1:I/72-I/78.
123. Riley AW, Spiel G, Coghill D, Döpfner M, Falissard B, Lorenzo MJ, Preuss U, Ralston SJ & ADORE Study Group: Factors related to Health-Related Quality of Life (HRQoL) among children with ADHD in Europe at entry into treatment. European Child and Adolescent Psychiatry 2006b; 15, supplement 1:I/38-I/45. (Pubitemid 46009494)
124. Roessner V, Banaschewski T, Fillmer-Otte A, Becker A, Albrecht B, Uebel H, Sergeant J, Tannock R, Rothenberger A: Color perception deficits in co-existing attention-deficit/hyperactivity disorder and chronic tic disorders. J Neural Transm 2008; 115(2): 235-239 (Pubitemid 351270109)
125. Roessner V, Banaschewski T, Rothenberger A. Neuropsychologie bei ADHS und Tic-Störungen - eine Follow-up- Untersuchung. Praxis der Kinderpsychologie und Kinderpsychiatrie 2006; 55, 314-327. (Pubitemid 43989999)
126. Roessner V, Banaschewski T, Rothenberger A: [Neuropsychological performance in ADHD and tic-disorders: a prospective 1-year follow-up]. Prax Kinderpsychol K 2006; 55(5): 314-327
127. Roessner V, Banaschewski T, Uebel H, Becker A, Rothenberger A: Neuronal network models of ADHD - lateralization with respect to interhemispheric connectivity reconsidered. Eur Child Adoles Psy 2004; 13 Suppl 1: I71-9. (Pubitemid 39165253)
128. Roessner V, Becker A, Banaschewski T, Freeman RD, Rothenberger A, Tourette Syndrome International Database Consortium: Developmental psychopathology of children and adolescents with Tourette syndrome - impact of ADHD. Eur Child Adoles Psy 2007; 16 Suppl 1: 24-35.
129. Roessner V, Becker A, Banaschewski T, Rothenberger A. Executive functions in children with chronic tic disorders with/without ADHD: new insights. Eur Child Adolesc Psychiatry 2007; 16 Suppl 1:36-44. (Pubitemid 47245231)
130. Roessner V, Becker A, Banaschewski T, Rothenberger A: Psychopathological profile in children with chronic tic disorder and co-existing ADHD: additive effects. J Abnorm Child Psych 2007; 35: 79-85. (Pubitemid 46399162)
131. Roessner V, Becker A, Rothenberger A, Rohde LA, Banaschewski T. A cross-cultural comparison between samples of Brazilian and German children with ADHD/HD using the Child Behavior Checklist. Eur Arch Psychiatry Clin Neurosci 2007; 257:352-359. (Pubitemid 47476723)
132. Roessner V, Becker A, Banaschewski T, Rothenberger A: Psychopathological profile in children with chronic tic disorder and co-existing ADHD: additive effects. Journal of Abnormal Child Psychology.2007; 35:79-85. (Pubitemid 46399162)
133. Roessner V, Robatzek M, Knapp G, Banaschewski T, Rothenberger A: First-onset tics in patients with attention-deficit-hyperactivity disorder: impact of stimulants. Dev Med Child Neurol 2006; 48(7): 616-621 (Pubitemid 43919072)
134. Roessner V, Uebel H, Becker A, Beck G, Bleich S, Rothenberger A: Serum level of semicarbazide-sensitive amine oxidase in children with ADHD. Behav Brain Funct 2006; 2(1): 5.. (Pubitemid 43676886)
135. Roessner V, Walitza S, Riederer F, Hünnerkopf R, Rothenberger A, Gerlach M, Moser A: Tetrahydroisoquinoline derivatives: a new perspective on monoaminergic dysfunction in children with ADHD? Behav Brain Funct 2007; 3: 64.
136. Romanos M*, Freitag C*, Jacob C*, Craig DW, Nguyen TT, Halperin R, Walitza S, Renner TJ, Seitz C, Romanos J, Palmason H, Heine M, Dempfle A, Windemuth-Kieselbach C, Sigmund J, Warnke A, Schäfer H, Meyer J, Stephan DA, Lesch KP: Genomewide linkage analysis of ADHD using high-density SNP arrays: novel loci at 5q13.1 and 14q12. Mol Psychiatry 2008; 13:522-30*equal contribution.
137. Rothenberger A, Becker A, Deutsche ADORE/FACE Studiengruppe (inkl. Dittmann RW): Assoziierte Störungen bei ADHS im Elternurteil und in der klinischen Einschätzung. (Symposium: Rothenberger A, Döpfner M: Ergebnisse einer vergleichenden Beobachtungsstudie zu ADHS: Die ADORE & FACE Studie.). In: Die Sprache in der Kinder- und Jugendpsychiatrie - Zur Bedeutung kommunikativer Prozesse in Diagnostik, Therapie und Forschung. Hrsg: Resch F. Vandenhoeck & Ruprecht, Göttingen; S. 177-178, 2005.
138. Rothenberger A, Coghill D, Döpfner M, Falissard B, Steinhausen HC: Naturalistic-observational studies in the framework of ADHD health care. Eur Child Adoles Psy 2006; 15 Suppl 1: i1-i3.. (Pubitemid 46009490)
139. Rothenberger A, Kirov R: Changes in sleep-wake behaviour may be more than just an epiphenomenon of ADHD (Open Peer Commentary). Behav Brain Sci 2005; 28: 429.. (Pubitemid 41440206)
140. Rothenberger A, Dankaerts M, Döpfner M, Sergeant J & Steinhausen HC: EINAQ - A European educational initiative on Attention-Deficit Hyperactivity Disorder and associated problems. European Child and Adolescent Psychiatry 2004; 13 (supplement 1): I/31-I/35. (Pubitemid 39165249)
141. Rothenberger A, David Coghill, Döpfner M, Fallisard B & Steinhausen H-C: Naturalistic-observational studies in the framework of ADHD health care. European Child and Adolescent Psychiatry 2006; 15, supplement 1:I/1-I/3. (Pubitemid 46009490)
142. Russell VA, Oades RD, Tannock R, Killeen PR, Auerbach JG, Johansen EB, Sagvolden T: Response variability in Attention-Deficit/Hyperactivity Disorder: a neuronal and glial energetics hypothesis. Behav Brain Funct 2006; 2:30. (Pubitemid 44680004)
143. Salbach H, Lenz K, Huss M, Vogel R, Felsing D, Lehmkuhl U: Die Wirksamkeit eines Gruppentrainings für Eltern hyperkinetischer Kinder. Z Kinder-Jugendpsychiatr. 2005; 33: 59-68.
144. Schimmelmann BG, Friedel S, Dempfle A, Warnke A, Lesch KP, Walitza S, Renner TJ, Romanos M, Herpertz-Dahlmann B, Linder M, Schäfer H, Seitz C, Palmason H, Freitag C, Meyer J, Konrad K, Hinney A, Hebebrand J: No evidence for preferential transmission of common valine allele of the Val66Met polymorphism of the brain-derived neurotrophic factor gene (BDNF) in ADHD. J Neural Transm. 2007; 114(4): 523-526 (Pubitemid 46474871)
145. Schneider M, Retz W, Freitag C, Irsch J, Graf P, Retz-Junginger P, Rösler M: Impaired cortical inhibition in adult ADHD patients: a study with transcranial magnetic stimulation. J Neural Transm Suppl. 2007; 72: 303-309
146. Schubert I, Köster I, Adam Chr, Ihle P, Ferber L v; Lehmkuhl G: «Hyperkinetische Störung als Krankenscheindiagnose bei Kindern und Jugendlichen» - eine versorgungsepidemiologische Studie auf der Basis der Versichertenstichprobe KV Hessen/AOK Hessen. Bericht an das Ministerium für Gesundheit und Soziale Sicherung. (Drucklegung durch Ministerium in Vorbereitung), 2003.
147. Schubert I, Köster I, Lehmkuhl G: Hyperkinetische Störungen. Aktuelle Daten zur Versorgungsepidemiologie in Hessen. Info.doc 2003; 8:44-46.
148. Schubert I; Köster I; Adam, Chr, Ihle P; Döpfner M, Lehmkuhl G: Psychopharmakaverordnung bei Kindern und Jugendlichen mit Behandlungsanlass «Hyperkinetische Störung ». Eine Untersuchung zur Arzneimittelanwendung in der ambulanten Versorgung auf der Basis der Versichertenstichprobe AOK Hessen/KV Hessen (1998-2001). Zeitschrift für Gesundheitswissenschaften 2003; 11:306-324.
149. Schubert S, Fegert JM, Schulze U: Atomoxetin bei Patienten mit Klinefelter Syndrom und Hyperkinetischer Störung des Sozialverhaltens. Monatsschr Kinderh 2007; 155:451-454. (Pubitemid 46895734)
150. Seifert J, Scheuerpflug P, Zillessen KE, Fallgatter A, Warnke A: Electrophysiological investigation of the effectiveness of methylphenidate in children with and without ADHD. J Neural Transm 2003; 110: 821-829. (Pubitemid 36783235)
151. Selch S, Lesch KP, Romanos M, Walitza S, Warnke A, Renner T, Jacob C, Romanos J, Ropers HH, Ullmann R. A genomewide duplication- and deletion analysis on patients with ADHD. Eur Neuropsychopharmacol 2007; 17 [Supplement 1]: S26-S27.
152. Sevecke K, Lehmkuhl G, Krischer M: ADHS und Persönlichkeitsstö rungen bei klinisch behandelten und inhaftierten Jugendlichen. Praxis der Kinderpsychologie und Kinderpsychiatrie 2008; 57: 641-661.
153. Sevecke K, Döpfner M: Das Vorgehen bei der kontrollierten Prüfung der Stimulanzientitration bei Schulkindern mit ADHS. Praktische Pädiatrie 2004; 10:404-406.
154. Sevecke K, Dreher J, Walger P, Junglas J, Lehmkuhl G: Aggressives Verhalten und Substanzmittelkonsum bei an Schizophrenie erkrankten Jugendlichen im Vergleich zu dissozialen Jugendlichen, eine follow-up Studie. Zeitschr Kinder-Jugendpsychiatrie Psychotherapie 2005; 33:105-112 (Pubitemid 40577189)
155. Simpson A, Kratochvil CJ, Newcorn JH, Allen AJ, Faries DE, Milton DR, Feldman PD, Michelson D, Wehmeier P, Dittmann RW, Biederman J: Wirksamkeit von Atomoxetin in placebokontrollierten Studien bei Kindern, Jugendlichen und Erwachsenen mit Aufmerksamkeits-defizit-/Hyperaktivitätsstörung. In: Die Sprache in der Kinder- und Jugendpsychiatrie - Zur Bedeutung kommunikativer Prozesse in Diagnostik, Therapie und Forschung. Hrsg: Resch F. Vandenhoeck & Ruprecht, Göttingen; S. 329, 2005.
156. Sinzig J, Döpfner M, Lehmkuhl G; German Methylphenidate Study Group, Uebel H, Schmeck K, Poustka F, Gerber WD, Günter M, Knölker U, Gehrke M, Hässler F, Resch F, Brünger M, Ose C, Fischer R: Long-acting methylphenidate has an effect on aggressive behavior in children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 2007; 17:421-432 (Pubitemid 47422214)
157. Sinzig J, Bruning N, Lehmkuhl G: Altersabhängige Unterschiede in neuropsychologischen Leistungsprofilen bei ADHS und Autismus. Zeitschrift für Kinder- und Jugendpsychiatrie 2007; 35:95-106. (Pubitemid 46524355)
158. Sinzig J, Döpfner M, Lehmkuhl G & German Methylphenidate Study Group: Long-acting methylphenidate has an effect on aggressive behavior in children with attention-deficit/hyperactivity disorder. Journal of Child & Adolescent Psychopharmacology 2007; 17:421-432.
159. Sinzig JK, Döpfner M, Plück J, Banaschewski T, Stephani U, Lehmkuhl G, Rothenberger A: [Does a morning dose of Methylphenidate Retard reduce hyperkinetic symptoms in the afternoon?]. Z Kinder Jug-Psych 2004; 32(4): 225-233
160. Sinzig J, Morsch D, Bruning N, Schmidt MH, Lehmkuhl G: Inhibition, flexibility, working memory and planning in autism spectrum disorders with and without comorbid ADHD-symptoms. Child and Adolescent Psychiatry and Mental Health 2008; 2:4. (Pubitemid 351827640)
161. Sinzig J, Morsch D, Lehmkuhl G: Do hyperactivity, impulsivity and inattention have an impact on the ability of facial affect recognition in children with autism and ADHD? Eur Child Adolesc Psychiatry 2008; 17:63-72.
162. Sonuga-Barke EJ, Brookes KJ, Buitelaar J, Anney R, Bitsakou P, Baeyens D, Buschgens C, Chen W, Christiansen H, Eisenberg J, Kuntsi J, Manor I, Meliá A, Mulligan A, Rommelse N, Müller UC, Uebel H, Banaschewski T, Ebstein R, Franke B, Gill M, Miranda A, Oades RD, Roeyers H, Rothenberger A, Sergeant J, Steinhausen HC, Thompson M, Taylor E, Asherson P, Faraone SV. Intelligence in DSM-IV combined type attention-deficit/hyperactivity disorder is not predicted by either dopamine receptor/transporter genes or other previously identified risk alleles for attention-deficit/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 2008; 147:316-319 (Pubitemid 351961674)
163. Spencer TJ, Zhang S, Ruff DD, Feldman P, Wehmeier P, Dittmann RW, Michelson D: Wachstum und Entwicklung von Kindern und Jugendlichen mit ADHS unter der Behandlung mit Atomoxetin. In: Die Sprache in der Kinder- und Jugendpsychiatrie - Zur Bedeutung kommunikativer Prozesse in Diagnostik, Therapie und Forschung. Hrsg: Resch F. Vandenhoeck & Ruprecht, Göttingen; S. 215, 2005.
164. Stadler C, Holtmann M, Claus D, Büttner G, Berger N, Maier J, Poustka F, Schmeck K: Familiäre Muster bei Störungen von Aufmerksamkeit und Impulskontrolle Praxis für Kinderpsychologie und Kinderpsychiatrie 2006;5:350-362.
165. Stadler C, Zepf FD, Demisch L, Schmitt M, Landgraf M, Poustka F: Influence of rapid tryptophan depletion on laboratory-provoked aggression in children with ADHD; accepted for publication in Neuropsychobiology.
166. Steinhausen HC, Nøvik TS, Baldursson G, Curatolo P, Lorenzo MJ, Rodrigues Pereira R, Ralston SJ, Rothenberger A, ADORE Study Group*: Co-existing psychiatric problems in ADHD in the ADORE cohort. Eur Child Adoles Psy 2006; 15 Suppl 1: i25-i29..
167. Ströhle A, Stoy M, Wrase J, Schwarzer S, Schlagenhauf F, Huss M, Hein J, Nedderhut A, Neumann B, Gregor A, Juckel G, Knutson B, Lehmkuhl U, Bauer M, Heinz A: Reward anticipation and outcomes in adult males with attention-deficit/hyperactivity disorder. Neuroimage 2008; 39: 966-972.
168. Tannock R, Banaschewski T, Gold D: Color naming deficits and attention-deficit/hyperactivity disorder: a retinal dopaminergic hypothesis. Behav Brain Funct 2006, 2: 4. (Pubitemid 43676887)
169. Taylor E, Döpfner M, Sergeant J, Asherson P, Banaschewski T, Buitelaar J, Coghill D, Danckaerts M, Rothenberger A, Sonuga-Barke E, Steinhausen HC, Zuddas A: European clinical guidelines for hyperkinetic disorder - first upgrade. Eur Child Adoles Psy 2004; 13 Suppl 1: I7-30. (Pubitemid 39172160)
170. Tiffin-Richards MC, Hasselhorn M, Richards ML, Banaschewski T, Rothenberger A: Time reproduction in finger tapping tasks by children with attention-deficit hyperactivity disorder and/or dyslexia. Dyslexia 2004; 10: 299-315. (Pubitemid 39534426)
171. Tiffin-Richards MC, Hasselhorn M, Woerner W, Rothenberger A, Banaschewski T Phonological short-term memory and central executive processing in attention-deficit/hyperactivity disorder with/without dyslexia - evidence of cognitive overlap. J Neural Transm 2008; 115: 227-34.. (Pubitemid 351270108)
172. Tucha L, Tucha O, Walitza S, Stasik D, Laufkötter R, Klein HE, Lange KW: Neuropsychological assessment of attention in adults with different subtypes of attention deficit hyperactivity disorder. J Neural Transm 2008; 115: 269-278.
173. Tucha O, Prell S, Mecklinger L, Bormann-Kischkel C, Sabine Kübber S, Linder M, Walitza S, Lange KW: Effects of methylphenidate on multiple components of attention in children with attention deficit hyperactivity disorder. Psychopharmacology 2006; 185: 315-326
174. Walitza S, Melfsen S, Herhaus G, Scheuerpflug P, Warnke A, Müller T, Lange KW, Gerlach M: Association of Parkinson's disease with symptoms of attention deficit hyperactivity disorder in childhood. J Neural Transm [Suppl 72] 2007: 311-315.
175. Walitza S, Renner TJ, Dempfle A, Konrad K, Wewetzer C, Halbach A, Herpertz-Dahlmann B, Remschmidt H, Smidt J, Linder M, Flierl L, Knolker U, Friedel S, Schafer H, Gross C, Hebebrand J, Warnke A, Lesch KP: Transmission disequilibrium of polymorphic variants in the tryptophan hydroxylase-2 gene in attention-deficit/hyperactivity disorder. Molecular Psychiatry 2005; 10:1126-1132. (Pubitemid 43251103)
176. Walitza S, Werner B, Romanos M, Warnke A, Gerlach M, Stopper H: Does methylphenidate cause a cytogenetic effect in children with attention deficit hyperactivity disorder. Environ Health Perspect 2007; 115: 936-940. (Pubitemid 46902250)
177. Wehmeier PM, Dittmann RW, Schacht A, Minarzyk A, Lehmann M, Sevecke K, Lehmkuhl G: Effectiveness of atomoxetine and quality of Life in children with attention-deficit/hyperactivity disorder as perceived by patients, parents and physicians in an open-Label Study. Journal of Child and Adolescent Psychopharmacology 2007; 17:813-829. (Pubitemid 351158598)
178. Wiater A, Lehmkuhl G, Mitschke A, Fricke L, von Widdern S, Scheuermann P, Breuer U: Lärm als Co-Faktor von Schlafstörungen und Hyperaktivität bei Grundschulkindern. Kinder- und Jugendarzt 2007; 38 Jg (2):97-102.
179. Wild-Wall N, Oades RD, Juran SA: Maturation processes in automatic change detection as revealed by event-related brain potentials and dipole source localization: significance for adult AD/HD. Int J Psychophysiol 2005; 58:34-46. (Pubitemid 41219518)
180. Wolf I, Ruf M, Schmidt MH, Ende G: Bildgebende Darstellung neurokognitiver Dysfunktionen bei der Aufmerksamkeitsdefizit-/ Hyperaktivitätsstörung. Radiologe 2005; 45:169-177.
181. Xu X, Aysimi E, Anney R, Brookes K, Franke B, Zhou K, Buschgens C, Chen W, Christiansen H, Eisenberg J, Gabriëls I, Manor I, Marco R, Müller UC, Mulligan A, Rommelse N, Thompson M, Uebel H, Banaschewski T, Buitelaar J, Ebstein R, Gill M, Miranda A, Mulas F, Oades RD, Roeyers H, Rothenberger A, Sergeant J, Sonuga-Barke E, Steinhausen HC, Taylor E, Faraone SV, Asherson P: No association between two polymorphisms of the serotonin transporter gene and combined type attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 2008; 150B: 154..
182. Yordanova J, Heinrich H, Kolev V, Rothenberger A: Increased event-related theta activity as a psychophysiological marker of comorbidity in children with tics and attention-deficit/hyperactivity disorders. Neuroimage 2006; 32: 940-955. (Pubitemid 44149137)
183. Zepf FD, Stadler C, Demisch L, Schmitt M, Landgraf M, Poustka F: Serotonergic functioning and trait-impulsivity in attention-deficit/ hyperactivity-disordered boys (ADHD): Influence of rapid tryptophan depletion. Hum Psychopharmacol 2008; 23: 43-51. (Pubitemid 351166067)
184. Zepf FD, Wöckel L, Poustka F, Holtmann M: Diminished 5-HT functioning in CBCL pediatric bipolar disorder profiled ADHD patients vs normal ADHD: Susceptibility to rapid tryptophan depletion influences reaction time performance. Hum Psychopharmacol 2008; 23: 291-299. (Pubitemid 351982666)
185. Zhou K, Asherson P, Sham P, Franke B, Anney RJ, Buitelaar J, Ebstein R, Gill M, Brookes K, Buschgens C, Campbell D, Chen W, Christiansen H, Fliers E, Gabriëls I, Johansson L, Marco R, Mulas F, Müller U, Mulligan A, Neale BM, Rijsdijk F, Rommelse N, Uebel H, Psychogiou L, Xu X, Banaschewski T, Sonuga-Barke E, Eisenberg J, Manor I, Miranda A, Oades RD, Roeyers H, Rothenberger A, Sergeant J, Steinhausen HC, Taylor E, Thompson M, Faraone SV. Linkage to Chromosome 1p36 for Attention-Deficit/Hyperactivity Disorder Traits in School and Home Settings. Biol Psychiatry 2008; 64: 571-576.
186. Zhou K, Chen W, Buitelaar J, Banaschewski T, Oades RD, Franke B, Sonuga-Barke E, Ebstein R, Eisenberg J, Gill M, Manor I, Miranda A, Mulas F, Roeyers H, Rothenberger A, Sergeant J, Steinhausen HC, Lasky-Su J, Taylor E, Brookes KJ, Xu X, Neale BM, Rijsdijk F, Thompson M, Asherson P, Faraone SV. Genetic heterogeneity in ADHD: DAT1 gene only affects probands without CD. Am J Med Genet B Neuropsychiatr Genet 2008; 147B: 1481-1487.
187. Brummelte S, Grund T, Moll GH, Teucher-Noodt G, Dawirs RR Environmental enrichment has no effect on the development of dopaminergic and GABAergic fibers during methylphendiate treatment of early traumatized gerbils. J Negat Results Biomed 2008; 16: 2. (Pubitemid 351794096)
188. Grund T, Lehmann K, Bock N, Rothenberger A, Teuchert-Noodt G. Influence of methylphenidate on brain development - an update of recent animal experiments. Behavioral and Brain Functions 2006; 10: 2:2. (Pubitemid 43676889)
189. Grund T, Teuchert-Noodt G, Busche A, Neddens J, Brummelte S, Moll GH, Dawirs R. Administration of oral methylphenidate during adolescence prevents suppressive development of dopamine projections into prefrontal cortex and amygdala after an early pharmacological challenge in gerbils. Brain Res 2007;1176: 124-132. (Pubitemid 47553113)
190. Himpel S, Bartels J, Zimdars K, Huether G, Adler L, Dawirs RR, Moll GH. Association between body weight of newborn rats and density of serotonin transporters in the frontal cortex at adulthood. J Neur Trans 2006; 113: 295-302. (Pubitemid 43201096)
191. Lehmann K, Rodrigues EG, Kratz O, Moll GH, Dawirs RR, Teuchert-Noodt G. Early preweaning methamphetamine and postweaning rearing conditions interfere with the development of peripheral stress parameters and neural growth factors in gerbils. Int J Neurosci 2007; 117: 1621-1638 (Pubitemid 47537046)
192. Neddens J, Bagorda F, Busche A, Horstmann S, Moll GH, Dawirs RR, Teuchert-Noodt G. Epigenetic factors differentially influence postnatal maturation of serotonin (5-HT) innervation in cerebral cortex of gerbils: interaction of rearing conditions and early methamphetamine challenge. Dev Brain Res 2003; 146: 119-130. (Pubitemid 37464918)
193. Albayrak O, Friedel S, Schimmelmann BG, Hinney A, Hebebrand J: Genetic aspects in attention-deficit/hyperactivity disorder. J Neural Transm 2008; 115:305-315
194. Asherson P, IMAGE Consortium: Attention-Deficit Hyperactivity Disorder in the post-genomic era. Eur Child Adoles Psy 2004; 13 Suppl 1: I50-70. (Pubitemid 39165252)
195. Banaschewski T, Coghill D, Santosh P, Zuddas A, Asherson P, Buitelaar J, Danckaerts M, Dopfner M, Faraone SV, Rothenberger A, Sergeant J, Steinhausen HC, Sonuga-Barke EJ, Taylor E. Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline. Eur Child Adolesc Psychiatry 2006; 15:476-495.
196. Banaschewski T, Hollis C, Oosterlaan J, Roeyers H, Rubia K, Willcutt E, Taylor E: Towards an understanding of unique and shared pathways in the psychopathophysiology of ADHD. Developmental Sci 2005; 8(2): 132-140 (Pubitemid 40344681)
197. Banaschewski T, Neale BM, Rothenberger A, Roessner V: Comorbidity of tic disorders; ADHD: conceptual and methodological considerations. Eur Child Adoles Psy 2007; 16 Suppl 1: 5-14.
198. Banaschewski T, Roessner V, Dittmann RW, Santosh PJ, Rothenberger A: Nonstimulant medications in the treatment of attention-deficit/hyperactivity disorder (ADHD). Eur Child Adoles Psy 2004; 13 Suppl 1:I102-116.
199. Banaschewski T, Siniatchkin M, Uebel H, Rothenberger A: [Compulsive phenomena in children with tic disorder and attention deficit-hyperactive disorder]. Z Kinder Jug-Psych 2003; 31(3): 203-211
200. Becker K, Holtmann M. The role of EEG in Attention-Deficit/Hyperactivity Disorder Expert Review of Neurotherapeutics 2006; 6:731-739.
201. Becker K, Wehmeier PM, Schmidt MH: The Noradrenergic Transmitter System in ADHD. Principles and Implications for Treatment. Thieme, Stuttgart, New York, 2005.
202. Buitelaar JK, Rothenberger A: Foreword - ADHD in the scientific and political context. Eur Child Adoles Psy 2004; 13 Suppl 1: I1-6.
203. Coghill D, Nigg J, Rothenberger A, Sonuga-Barke E, Tannock R: Whither causal models in the neuroscience of ADHD? Developmental Sci 2005; 8(2): 105-114
204. Döpfner M, Rothenberger A, Sonuga-Barke E: Areas for future investment in the field of ADHD: preschoolers and clinical networks. Eur Child Adoles Psy 2004; 13 Suppl 1: I130-5. (Pubitemid 39165258)
205. Döpfner M, Rothenberger A: Behavior therapy in tic-disorders with co-existing ADHD. Eur Child Adoles Psy 2007; 16 Suppl 1: 89-99.
206. Durston S, Konrad K: Integrating genetic, psychopharmacological and neuroimaging studies: A converging methods approach to understanding the neurobiology of ADHD. Dev Rev. 2007; 27(3): 374-395.
207. Faraone SV, Asherson P and the IMAGE Consortium: The molecular genetics of ADHD: a view from the IMAGE project. Psychiat times (Internet-Ausgabe) 2005 22: 9.
208. Friedel S, Heiser P, Dempfle A, Konrad K, Hebebrand J: Molecular genetic aspects of ADHS. In: Progress in Attention Deficit/Hyperactivity Disorder Research, Eds: Oades R, Nova Science Publishers Inc. New York, pp 35-39, 2006.
209. Gillberg C, Gillberg IC, Rasmussen P, Kadesjö B, Söderström H, Råstam M, Johnson M, Rothenberger A, Niklasson L: Co-existing disorders in ADHD - implications for diagnosis and intervention. Eur Child Adoles Psy 2004; 13 Suppl 1: I80-92. (Pubitemid 39165254)
210. Heinrich H, Gevensleben H, Strehl U: Annotation: Neurofeedback - Train your brain to train behaviour. J Child Psychol Psychiatry 2007; 48(1): 3-16. (Pubitemid 46140509)
211. Heiser P, Friedel S, Dempfle A, Konrad K, Smidt J, Grabarkiewicz J, Herpertz-Dahlmann B, Remschmidt H, Hebebrand J: Molecular genetic aspects of attention-deficit/hyperactivity disorder. Neurosci Biobehav Rev 2004; 28:625-641 (Pubitemid 39446486)
212. Herpertz-Dahlmann B, Konrad K, Herpertz SC: Intervention, Treatment and Management of ADHD. In: International Handbook On Psychopathic Disorders and the Law Vol1, Eds: Felthous AR, Saß H, Wiley, Ltd England, pp 383-395, 2007.
213. Herpertz-Dahlmann B, Konrad K, Herpertz SC: The Role of ADHD in the Etiology and Outcome of Antisocial Behavior and Psychopathy. In: International Handbook On Psychopathic Disorders and the Law Vol1, Eds:Felthous AR, Saß H, Wiley, Ltd England, pp 199-216, 2007.
214. Himpel S, Banaschewski T, Heise CA, Rothenberger A: The safety of non-stimulant agents for the treatment of attention-deficit hyperactivity disorder. Expert Opin Drug Saf 2005; 4(2): 311-321 (Pubitemid 40867341)
215. Konrad K: Catecholamines and attentional functioning in children with ADHD. In: Progress in Attention Deficit/Hyperactivity Disorder Research, Ed: Oades R, Nova Science Publishers Inc. New York, pp 155-169, 2006.
216. Mehler-Wex C, Riederer P, Gerlach M: Dopaminergic dysbalance in distinct basal ganglia neurocircuits: implications for the pathophysiology of Parkinson's disease, schizophrenia and attention deficit hyperactivity disorder. Neurotox Res 2006; 10: 167-179.
217. Oades RD, Sadile AG, Sagvolden T, Viggiano D, Zuddas A, Devoto P, Aase H, Johansen EB, Ruocco LA, Russell VA. The control of responsiveness in ADHD by catecholamines: evidence for dopaminergic, noradrenergic and interactive roles. Dev Sci 2005; 8:122-131 (Pubitemid 40350166)
218. Oades RD. Function and dysfunction of monoamine interactions in children and adolescents with AD/HD. EXS. 2006; 98:207-244
219. Oades RD. Role of the serotonin system in ADHD: treatment implications. Expert Rev Neurother 2007; 7:1357-1374 (Pubitemid 350012724)
220. Rothenberger A, Coghill D, Döpfner M, Falissard B, Steinhausen HC, ADORE Study Group Baseline data of a large-sale longitudinal study - Editorial. Eur Child Adoles Psy 2006; 15: 1.
221. Rothenberger A, Banaschewski T, Heinrich H, Moll GH, Sergeant J: Cortical excitability in ADHD as measured by transcranial magnetic stimulation. In: McBurnett K, Pfiffner L (Hrsg.): Attention deficit hyperactivity disorder: Concepts, controversies, new directions (Medical Psychiatry). Informa Healthcare 2007; 125-136.
222. Rothenberger A, Banaschewski T: Informing the ADHD debate. Scientific American Mind 2004; 14: 50-55.
223. Rothenberger A, Roessner V, Banaschewski T, Leckman JF. Co-existence of tic disorders and attention-deficit/hyperactivity disorder-recent advances in understanding and treatment. Eur Child Adolesc Psychiatry 2007; 16 Suppl 1:1-4. (Pubitemid 47245227)
224. Schmidt JK, Doepfner M & Lehmkuhl G: Long-acting methylphenidate (Medikinet Retard®) in ADHD - efficacy in ADHD and aggressive behavior. In: Findling, R, Davidson, PA, Enright, T, Figge, K & Dade, N (Eds.) The scientific proceedings of the 50th anniversary meeting of the American Academy
225. Sinzig JK, Lehmkuhl G: What do we know about the serotonergic genetic heterogeneity in attention deficit/hyperactivity and autistic disorders? Psychopathology 2007; 40:329-337.
226. Stopper H, Walitza S, Warnke A, Gerlach M: Brief review of available evidence concerning the potential induction of genomic damage by methylphenidate. J Neural Transm 2008; 115: 331-334.
227. Sukhodolsky DG, Leckman JF, Rothenberger A, Scahill L: The role of abnormal neural oscillations in the pathophysiology of co-occurring Tourette syndrome and attention-deficit/hyperactivity disorder. Eur Child Adoles Psy 2007; 16 Suppl 1: 51-59 (Pubitemid 47248499)
228. Taylor E, Döpfner M, Sergeant J, Asherson P, Banaschewski T, Buitelaar J, Coghill D, Danckaerts M, Rothenberger A, Sonuga Barke E, Steinhausen H-C & Zuddas A: Clinical guidelines for hyperkinetic disorder- first upgrade. European Child & Adolescent Psychiatry 2004; 13 (supplement 1):I/7-I/30.